healthcare medical device: August 2020

Monday 31 August 2020

Big Data in Healthcare Market Covering Competitive Scenario & Market Dynamics throughout 2022

Market Research Future latest research report on BIG DATA IN HEALTHCARE MARKET features a comprehensive outlook pertaining to market valuations, market share, and profit estimations. The report precisely describes key obstacles and opportunities for growth, while drawing out competitive standing of market majors, including their portfolio and growth strategies.

Also Read : https://www.medgadget.com/2020/06/big-data-in-healthcare-market-size-worth-usd-17278-million-at-a-20-69-cagr-by-2022-covid-19-impact-analysis-share-value-emerging-trends-sales-growth-and-future-insights.html

Market Analysis

The Big Data in Healthcare Market is predicted to touch USD 17,278.13 million at a 20.69% CAGR between 2015- 2022, as per Market Research Future’s new report. Big data, simply put, is the digitalization of the healthcare data. It is widely used in the healthcare sector to keep track of heaps of data, which is generated from various healthcare processes like medical imaging, clinical data, pharmacy, clinical decision support systems, insurance, and other types of administrative records.

Various factors are propelling the growth of big data in healthcare market. Such factors which support the huge big data spending in the healthcare market, as per the latest report by MRFR include increasing use by pharmaceutical & biotechnological companies especially for product cross-selling, advancement in technology, need to cut down healthcare costs, augment patient outcomes and resource management, deployment of cloud, governments & healthcare agencies focusing on the implantation of big data in healthcare to reduce costs & offer cost-effective treatment, increasing use for medical procedures turning digital, financial risk management, and regulatory compliance management. Meanwhile, the growth of global big data analytics in healthcare market stems from the requirement for analysis, management, and integration of huge volumes of data.

On the flip side, security concerns, data privacy issues, and strict protocols may impede the growth of the big data healthcare market during the forecast period.

Request For Free Sample Copy : https://www.marketresearchfuture.com/sample_request/948

Scope of the Report

The report offers an analysis of various parameters of the big data in healthcare market. The market has been segmented based on analytical service types, hardware, software, and analytical service applications. It also sheds light on the market size, market share, market trends, and regional segmentation.

Market Segmentation

The big data in healthcare market is segmented on the basis of analytical service types, hardware, software, and analytical service applications.

On the basis of hardware, the big data in healthcare market is segmented into firewalls, routers, access points, data storage, email servers, and VPNs.

On the basis of software, the big data in healthcare market is segmented into EHR, practice management, revenue cycle management, and workforce management.

On the basis of analytical service types, the market has been segmented into prescriptive, descriptive, and predictive.

On the basis of analytical service applications, the market is segmented into operational analysis, clinical analysis, and financial analysis.

Browse Complete Report : https://www.marketresearchfuture.com/reports/global-big-data-healthcare-market-948

Regional Analysis

Geographically, the big data in healthcare market has been segmented into Europe, North America, the Middle East & Africa, and the Asia Pacific (APAC). Among these, the Americas is likely to spearhead the market over the forecast period. The concentration of leading players, extensive usage of IT, rising use of new technologies, and rising investment on healthcare are adding to the growth of the market in the region.

In Europe, the big data in healthcare market will hold the second-largest share over the forecast period. Increased spending on healthcare is adding to the growth of the market in the region.

In the APAC region, the big data in healthcare market will grow at a fast pace over the forecast period. Increasing use of new & innovative technologies coupled with more focus on healthcare is adding to the growth of the market in the region.

In the MEA, the big data in healthcare market is likely to have notable growth over the forecast period. The market in the African region will have a small share for weak economic conditions & slow development of the healthcare industry. In the East region, the Gulf nations are adding to the growth of the market.

Key Players

Cerner Corporation, Xerox, Philips, Mckesson, Cognizant, Optum, GE Healthcare, Siemens, and Dell, among others, are the notable players profiled in the big data in healthcare market.

NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and Wherever Required We Will be Considering Covid19 Footprints for a Better Analysis of Markets and Industries. Cordially Get in Touch for More Details.

Mammography Market Size: In-Depth Analysis on Market Dynamics, Segmentation & Emerging Growth Factors 2025

Market Research Future latest research report on MAMMOGRAPHY MARKET features a comprehensive outlook pertaining to market valuations, market share, and profit estimations. The report precisely describes key obstacles and opportunities for growth, while drawing out competitive standing of market majors, including their portfolio and growth strategies.

Mammography Market Research Report: By Type (Screening Mammogram and Diagnostic Mammogram), Treatment (Digital Systems, Analog Systems, Breast Tomosynthesis, Film Screen Systems and others), End-User (Hospitals, Specialty Clinics, Diagnostic Centers, Research Institutes and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) – Forecast till 2025

Also Read :https://www.marketwatch.com/press-release/mammography-market-trends-analysis-future-growth-share-value-regional-outlook-covid-19-impact-and-global-industry-dynamics-by-2025-2020-08-21

The high incidence of breast cancer globally has warranted the need for preventive measures by users. Mammography is the process of taking pictures (mammograms) of breast using X-rays for diagnosis and screening purposes. Early detection of malignant growth or tumors can assist clinicians to offer the right diagnosis. The global mammography market report by Market Research Future (MRFR) covers the scope of the technology with respect to developed and developing economies.

Market Outlook
The global Mammography Market Size is projected to experience a stupendous growth rate of 22.60% from 2017 to 2022 (forecast period). It is predicted to expand in size due to rising incidence of breast cancer cases as well as awareness of the technology. Approval of policies such as the Mammography Quality Standards Act (MQSA) which ensures quality care in mammography is likely to push the market demand.
Patients with hormonal disorders and elderly patients who are vulnerable to breast cancer offer opportunities for the market. Rising cases of hormonal imbalance and the rising geriatric population are viable factors of the market. For instance, menopausal hormone therapy can cause breast cancer. Increased healthcare expenditure as well as adoption by leading clinics and hospitals can spur the market growth exponentially.

Segmentation Analysis
The global mammography market is segmented by technology and application.
By technology, it is segmented into analog, digital mammography, C-view 2D, 3D mammography, breast tomosynthesis contrast enhance tomography, and others. Digital mammography held the largest market share due to preference of the technology for converting mammographic pictures into digital images. 3D mammography is expected to be the largest segment by 2022 due to the capacity of the technology for pinpointing breast lesions and reduce the large number of breast cancer cases. The technology can capture images of the breast from different angles to give clinicians and doctors for rapid diagnosis of patients. According to the Radiological Society of North America, 3D mammography or digital breast tomosynthesis (DBT) can significantly reduce breast biopsy rates.

By application, it is segmented into diagnostic, screening, and others. The screening segment is likely to garner significant revenue due to high cases of cancer among women. Reduction of detection challenges due to adoption of DBT and digital mammography can drive segment growth.

Request For Free Sample Copy : https://www.marketresearchfuture.com/sample_request/2443

Region Analysis
Geographically, the mammography market comprises Asia Pacific, Americas, the Middle East & Africa, and Europe.
Within Americas, North America is expected to be the leading region in the global mammography market till 2022. The Americas can exhibit a superb growth rate during the forecast period due to adoption of latest technology, advanced healthcare infrastructure, and presence of major companies. Increasing government support for research and development can spur market growth.
APAC can grow at a swift pace due to presence of developing economies of China and India and huge patient pool. According to a report by Pfizer, a leading pharmaceutical company, 6.7 million cancer cases were registered in 2012. High prevalence of breast cancer combined with leading number of working women as well as initiatives by nations to introduce screening and diagnostic camps can work favorably for the market.
The Europe region is predicted to be the second-largest region after North America due to Germany and the U.K.
Within MEA, the Middle East is the biggest contributor to the market due to huge healthcare spending and presence of booming economies.

Browse Complete Toc :https://www.marketresearchfuture.com/reports/mammography-market-2443

Competitive Landscape
Key players in the mammography market include Siemens Healthcare GmbH, Carestream Health, Inc., Shimadzu Corporation, Toshiba Medical Systems Corporation, FUJIFILM Holdings Corporation, Hitachi Medical Corporation, Koninklijke Philips, Hologic, Inc., General Electric Company, and others.

Body Contouring Market Trends Size, Future Scope, Demands and Projected Industry Growths to 2023

Market Research Future latest research report on BODY CONTOURING MARKET features a comprehensive outlook pertaining to market valuations, market share, and profit estimations. The report precisely describes key obstacles and opportunities for growth, while drawing out competitive standing of market majors, including their portfolio and growth strategies.

Also Read : https://www.marketwatch.com/press-release/covid-19-impact-on-body-contouring-market-size-trends-analysis-leading-players-future-insights-and-growth-estimation-by-2023-2020-06-19

Market Research Future Published a Half Cooked Research Report on Body Contouring Market Research Report- Forecast To 2023
Body Contouring Market Research Report, By Devices (Non-Invasive Devices, Minimally Invasive Devices & Invasive Devices) – Forecast Till 2023

Market Insights

Body Contouring Market Trends is a process by which the body part is adjusted or altered to enhance the appearance, which refers to the removal of excess body fat. The increase in the obese population is the main driver of the market. Along with these technological advancements, the enhancement of the most successful surgical treatment has spurred market growth. Due to the growing influence of social media, the millennial generation is becoming more inclined towards enhancing their physical appearance. As a result, it has increased dependency on various contour products for a refined body. In addition, the availability of simple payment methods has made it easy to access the procedures for the patients, which contributes to market growth. In addition, technological developments have made these procedures more accurate and efficient, stimulating the market.
The growing number of the aging population and the introduction of advanced products by market participants are other market factors. In addition, the benefits of body contouring procedures should increase the market growth. High scale development in healthcare sector specifically in emerging nations is predicted to support the growth of the global market.
Moreover, several factors, such as increased disposable income, rising geriatric population, technological progress, and greater aesthetic awareness, should lead to market growth over the forecast period. Important market trends include consolidation of the procurement market, changes in consumer preferences, increased body use through men’s contours, and the transition to the customer. In addition, problems such as strict regulations and the high costs of procedures hamper market growth prospects.

Request For Free Sample Copy :
https://www.marketresearchfuture.com/sample_request/1343

Market Segmentation

The global body contouring Surgery market is bifurcated on the type of devices in invasive devices, minimally invasive devices, and noninvasive devices. Noninvasive devices are also subdivided into radiofrequency lipoplasty devices and ultra-intensive high intensity lipoplasty devices.
Minimally invasive devices are segmented into laser-assisted lipolysis devices, and radiofrequency assisted liposuction device; and invasive devices are segmented into ultrasound-assisted liposuction devices and others.
Regional Insights
Region-wise, North America holds the dominance of the global body contouring market. About 55% of the total North American population is overweight and obese. More spending on health care and government support for research and development on different surgical devices and procedures spurred market growth.Europe is the second-largest market, followed by the Asia Pacific region for the development of the body contour market in this region, due to the growing demand for better treatments and aids and the rising occurrence of diseases such as obesity and diabetes.Asia Pacific market is anticipated to show moderate growth trends owing to spreading awareness about the benefits of body contouring and its impact on health, both aesthetically and functionally.

Browse Complete Toc : https://www.marketresearchfuture.com/reports/body-contouring-market-1343
Key Players

The key players contributing and supporting the growth of the global contouring surgery market are Meridian, Alma Lasers, Syneron Medical, Cynosure, Palomar Medical Technologies, Invasix Aesthetic Solutions, Lumenis, Valeant, Cutera, GlobalMed Technologies, Asclepion Laser Technologies, Erchonia, Andrew Technologies, BTL Industries, Wells Johnson Company., Fotona, GlobalMed Technologies, Chromogenex, Human Med, and InMode. The majority of the market players are more inclined towards developing new devices and procedures, expansion in developing markets, and acquisition of technology companies for foreseen developments.Recent Updates
One of the leading companies in supervised wellness and weight loss, California-based Lindora, made an investment with the acquisition of new set of Zerona Z6 body contouring machines. The inclusion of Zerona Z6 body in Lindora’s services would help the company to be a leader in body contouring services in west coast area.

Growth of e Health Services Market Size Projected to Amplify During 2017-2023

Market Research Future latest research report on E HEALTH SERVICES MARKET features a comprehensive outlook pertaining to market valuations, market share, and profit estimations. The report precisely describes key obstacles and opportunities for growth, while drawing out competitive standing of market majors, including their portfolio and growth.

Also Read : http://www.marketwatch.com/story/e-health-services-market-growth-estimation-future-trends-covid-19-impact-analysis-share-value-research-insights-and-dynamics-by-2023-2020-07-16

Overview:

The global e Health Services Market Size is slated to surpass USD 270 billion by 2023, with a 12.9% CAGR during the forecast period (2018-2023). Market Research Future (MRFR) discussed various factors in the report that would trigger a rise in the ehealth services market share.

Market Drivers:

Among prominent drivers, facilities of providing consultation from a distance, reducing the waiting time, curbing the chances of contracting contagious diseases, better digital facilities, and others are expected to set up the market for better momentum. Its ability to reduce cost, pressure from hospitals, and improve quality are expected to boost market growth. In emerging countries, governments are spending more on infrastructure to clear a path for better integration of this system, which will propel the expansion rate of the market.

However, its initial cost of installation and lack of digital awareness among the people from the elderly generation and in rural areas can prohibit market growth.

Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/1252

Segmentation:

The global ehealth services market has been studied by MRFR experts and their report reveals a segmentation based on type, end user, and service. This is going to help in understanding the ehealth digital service infrastructure.

By type, the global market for e-health services includes ePrescribing, Electronic Health Records (EHR), big data systems, Telemedicine, Consumer health IT, Clinical Decision Support System (CDSS), and Knowledge Management System (KMS).

By service, the global market for ehealth services has been segmented into clinical services, administrative services, and financial services.

By end user, the global market report deals with segments like health insurance companies, clinics, hospitals, and others.

Regional Analysis:

The Americas can retain its dominance by providing backup to the system with proper digital support and funding. In the US and Canada, this market will gain more. In Europe, this market will be backed by Italy, France, Germany, the UK, and other affluent countries.

Browse Complete Report: https://www.marketresearchfuture.com/reports/e-health-services-market-1252

Competitive Landscape:

The potential of the eHealth market is huge and is rightly getting explored by top companies like Allscripts Healthcare Solutions Inc. (U.S), IBM Corporation (U.S), McKinsey & Co. (U.S), GE Healthcare (U.S), Epocrates Inc. (U.S), Telecare Corp. (U.S), Motion Computing Inc. (U.S), Apple (U.S), Boston Scientific Corp (U.S), GE Healthcare (U.S), Proteus Digital Health (U.S), Cerner (U.S), and others. These companies are creating grounds for further exploration both in terms of reach and product portfolio using methods like mergers, innovations, branding, partnerships, acquisitions, hiking the investment for research-related activities, and others.

Industry News:

The impact of the COVID-19 crisis has been substantial in the healthcare sector. The industry is witnessing some upheaval in structure as several options are getting tailwinds to normalize the process after the initial disruption. This pandemic crisis was all too sudden and in most of the countries, people were not prepared to handle it at all. Its presence among the people is threatening as the disease is contagious. That is why people around the world were advised to maintain social distancing, which is true in the healthcare sector as well. This has triggered a growth in ehealth or digital health. In fact, to back it up with adequate connectivity, companies are increasing their expenditures and forming collaborations. For instance, in June 2020, a report came out declaring the extension of the collaboration between SkyNet and SES Networks to support the Colombian Amazonas where businesses, government entities, local residents, and the San Rafael de Leticia Hospital are all benefiting from this joint venture and modification in net speed.

Friday 28 August 2020

Advance Anesthesia Monitoring Devices Market Share Covering Competitive Scenario & Market Dynamics throughout 2023

Advance Anesthesia Monitoring Devices Market research report: by type of product (basic anesthesia monitors, advanced anesthesia monitors, integrated anesthesia workstations), by end users (hospitals, private clinics, ambulatory services and others) – Global forecast till 2023

The Advance Anesthesia Monitoring Devices Market Share has been continuously witnessing outstanding demand. Undeniably, advances in healthcare technology are supporting market growth. These advanced technologies have brought a lot many changes in anesthesia monitoring, which allow sedation levels monitoring during anesthesia, using various electroencephalographic (EEG) indices.

Earlier anesthetists had limited access to monitor vital checks during anesthesia; all they could assess included blood pressure, heart & respiratory rate, body temperature, urine volume, and body movement. However, with the recent technological advances, percutaneous oxygen saturation, end-tidal concentrations of oxygen, carbon dioxide, and inhalation anesthetics can be monitored accurately.

Such improved abilities of these devices in anesthesia monitoring act as a major driving force pushing their uptake across the medical facilities. Moreover, increasing numbers of surgeries across the globe drive the size of the advance anesthesia monitoring devices market. Additionally, increasing demand for advanced anesthesia monitoring devices from critical care units increases the share of the market on the furthered heights.

Market Research Future (MRFR) states that the global market for advance anesthesia monitoring devices is estimated to register spectacular growth records by 2023, increasing at 10.3% CAGR during the review period (2017-2023). Recent market trends indicate a heavy rise in the shares of the advance anesthesia monitoring devices market. Besides, new developing techniques can also result in aiding substantial growth for the market.

Increasing numbers of surgical procedures in North America, Europe, and other developing nations and raising awareness for healthcare are some of the key growth influencers for the advanced anesthesia monitoring devices market. On the other hand, the higher costs of these devices and inadequate reimbursements provided by the governments, in turn, might act as significant growth impeding factors.

Advance Anesthesia Monitoring Devices Market – Segmentation

MRFR has segmented the market into three main dynamics to widen the scope of understanding,
By Type of Product : Basic/Primary Anesthesia Monitors, Advanced Anesthesia Monitors, Integrated Anesthesia Workstation, among others.
By End-users : Hospitals, Private Clinics, Ambulatory Services, and others.
By Regions : Europe, Americas, Asia Pacific, Middle East & Africa, and Rest-of-the-World.

Request For Free Sample Copy : https://www.marketresearchfuture.com/sample_request/1071

Global Advance Anesthesia Monitoring Devices Market – Regional Analysis

North America leads the global advance anaesthesia monitoring devices market, accounting for the worldwide highest adoption across the region. Rising diagnosed chronic disease cases and growing numbers of surgeries to treat them, alongside the rising accident cases requiring surgical processes, drive the growth of the regional market. Besides, factors such as the favorable conditions for research & development and the early uptake of advanced technologies for the development of these devices foster the regional market growth.

The advance anesthesia monitoring devices in Europe stand accounts for the second-leading market, globally. The European healthcare industry is currently booming owing to the increasing number of medical professionals and growing awareness. The number of various surgeries taking place, specifically in Germany, France, and Italy, are steadily increasing. Augmenting demand for streamlined operations in major health facilities is predominantly driving market growth.

The Asia Pacific advance anaesthesia monitoring devices market is rapidly emerging as a promising market, globally. The technological growth in India and China is changing the dynamics of healthcare. Moreover, the rapidly improving medical technology and more advancements in improving anesthesia monitoring devices boost the growth of the market.

Advance Anesthesia Monitoring Devices Market – Competitive Analysis

Highly competitive, the advance anaesthesia monitoring devices market appears to be fragmented, with many well-established players inspires a competitive landscape. Players adopt strategies like mergers & acquisitions, collaboration, expansion, and product & technology launch to make sure that the market becomes dynamic. Substantial investments are transpired in R&D to bring betterment in the existing products as well as to develop new ones.

Major Players:

Players leading the global advance anaesthesia monitoring devices market include General Electric Company (US), Nihon Kohden Corporation (China), Masimo (US), Medtronic (US), Infiniummedical (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Drägerwerk AG & Co. KGaA (Germany), Sedana Medical AB (Sweden), Smiths Medical (UK), Maquet Holding B V & Co. KG. (Germany), OSI Systems (US), Teleflex Incorporated (US), Getinge AB (Sweden), ResMed (US), Fisher & Paykel Healthcare Limited (New Zealand), Intersurgical Ltd (UK), and Phillips Plastics Corporation. (The Netherland), among others.

Chronic Idiopathic Constipation Treatment Market Size, Growth Factors, Market Drivers, Segmentations, Key Players, Analysis & Forecast by 2023

Chronic Idiopathic Constipation Treatment Market Size Research Report: By Diagnosis (Blood Tests, Sigmoidoscopy, Colonoscopy, Balloon Expulsion Test, Anorectal Manometry), Treatment (Drugs), End-User (Hospitals & Clinics, Diagnostic Centers) – Global Forecast Till 2023

Market Highlights

The market in Asia Pacific is expected to grow rapidly in the coming years. By studying and analyzing the market, it shows that this region has a good growth potential due to increasing unhealthy eating habits and unhygienic conditions. The other major chronic disease found in this region is the gastric cancer.

Segmentation

The global Chronic Idiopathic Constipation Market is segmented on the basis of diagnosis, treatment, and end-user. On the basis of diagnosis, the market is segmented into blood tests, sigmoidoscopy, colonoscopy, balloon expulsion tests, anorectal manometry, colonic transit study, defecography, and others. On the basis of treatment, the market is segmented into drug and surgery. Drugs are further segmented into acid neutralizers, laxatives and antidiarrheal, antiemetics, antiulcer, lubiprostone (amitiza) and linaclotide (linzess), misoprostol (Cytotec), colchicine/probenecid (Col-Probenecid) and Onabotulinumtoxin A (also called botulinum toxin type A or Botox), and others. On the basis of end-user, the market is segmented into hospitals, gastroenterology clinics, diagnostic centers, and others.

Request For Free Sample Copy : https://www.marketresearchfuture.com/sample_request/5931

Regional Analysis

The Americas dominates the global chronic idiopathic constipation market owing to the increasing prevalence of chronic constipation and the presence of a well-developed healthcare sector within the region. Moreover, the increasing healthcare expenditure and the presence of key players within regional boundaries provide a favorable background for the market growth.Europe is the second largest in the global chronic idiopathic constipation market. Factors such as the increasing availability of funds for research and a huge patient population followed by a well-developed healthcare sector drive the market within the region.Asia Pacific is estimated to be the fastest growing market for chronic idiopathic constipation. This can be attributed to the presence of developing economies such as India and China and a huge patient population. Moreover, the increasing healthcare expenditure and a rapidly developing healthcare sector boost the market growth within the region.On the other hand, the Middle East and Africa has the least share in the global chronic idiopathic constipation market due to the low per capita healthcare expenditure and stringent government policies, especially within the African region. It is estimated that the Middle East holds a majority of the market within the Middle Eastern and African region.

Browse Complete Toc : https://www.marketresearchfuture.com/reports/chronic-idiopathic-constipation-market-5931

Key Players

Some of the key players in this market are Actavis (U.S.), Chugai Pharmaceutical (Japan), Ferring International Center S.A.(Switzerland), Synergy Pharmaceuticals (U.S.), Pfizer Inc (U.S.), GlaxoSmithKline (U.K.), Sanofi (France), Bayer (Germany), Salix Pharmaceuticals Ltd (U.S.), Sucampo Pharmaceuticals Inc (U.S.), Ironwood Pharmaceuticals (U.S.), Progenics Pharmaceuticals (U.S.), F. Hoffmann-La Roche AG (Switzerland), Boehringer Ingelheim GmbH (Germany), Daewoong Co. Ltd.(South Korea), Synergy Pharmaceuticals, Inc. (U.S.), and others.

Oral Cancer Treatment Market Size: Development, Growth, Trends, Demand, Analysis and Forecast 2023

Oral Cancer Treatment Market Research Report, By Type (Squamous Cell Carcinoma, Minor Salivary Gland Carcinomas), By Treatment (Surgery, Radiotherapy, Chemotherapy), By End Users (Research Organization, Academic Institutes) – Global Forecast till 2023

Regional Analysis:

By region, the global Oral Cancer Treatment Market Size has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa (MEA). Americas is projected to lead the global market owing to the exponentially rising patient population. The region is also witnessing a drastic rise in cancer expenditure which is forecasted to favor the expansion of the oral cancer treatment market in the region. Europe is the second-largest market for oral cancer. Rising investments in research & development are anticipated to fuel the growth of the oral cancer treatment market in the region. Asia Pacific has been projected to expand at the highest CAGR over the assessment period. The Middle East & Africa is poised to retain the least share of the market in the forthcoming years.

Oral Cancer Treatment Market Synopsis:

The treatment for oral cancer is a prime area of research as it is generally discovered late in its development. Industry leaders are emphasizing on the development of more effective diagnosis. Market Research Future (MRFR) has found out in its latest study that the global oral cancer treatment market is anticipated to exhibit a CAGR of 7.1% during the forecast period 2019 to 2023. The need for early detection of oral cancer is expected to boost the revenue growth of the market in the years to come.

The increasing burden of the disease is poised to catapult the oral cancer treatment market on an upward trajectory in the nearby future. As per the statistics presented by the Oral Cancer Foundation, 53,000 Americans are estimated to be diagnosed with oral or oropharyngeal cancer in 2019. Habits such as tobacco addiction trigger the rising risk of developing oral cancer. Increasing cases of smoking addiction are anticipated to propel the expansion of the oral cancer market in the forthcoming years.

The rising healthcare expenditure is likely to influence the growth pattern of the market positively over the next couple of years. On the contrary, the risk of recurrence of the disease, coupled with the adverse effects associated with the treatment, remains an impediment to market growth. In addition, the high cost of the treatment is expected to check the proliferation of the oral cancer treatment market across the review period.

Market Segmentation:

The global oral cancer treatment market, by type, has been segmented into verrucous carcinoma, squamous cell carcinoma, lymphomas, minor salivary gland carcinomas, and others.

On the basis of treatment, the oral cancer treatment market has been segmented into surgery, chemotherapy, radiotherapy, photodynamic therapy (PDT), and others. The surgery segment is further sub-segmented into glossectomy, tumor resection, Mohs micrographic surgery, laryngectomy, and others. The chemotherapy segment has been sub-segmented into carboplatin, cisplatin, 5-fluorouracil (5-FU), and others.

Based on end-users, the global oral cancer treatment market has been segmented into hospitals & clinics, academic institutes, research organization, and others.

Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/1820

Competitive Tracking:

The key players participating in the global oral cancer treatment market are Qilu Pharmaceutical Co., Ltd. (Asia Pacific), Bristol-Myers Squibb Company (U.S.) Teva Pharmaceutical Industries Ltd. (Israel), F. Hoffmann-La Roche Ltd (Europe), Eli Lilly and Company. (U.S.), Merck & Co., Inc. (U.S.), Pfizer Inc. (U.S.), and Novartis AG (Europe).

Industry News:

In May 2019, Bristol-Myers Squibb Company, an American pharmaceutical company, participated in the UBS Global Healthcare Conference.

In January 2019, an American pharmaceutical company, Bristol-Myers Squibb Company, announced its plan of acquiring Celgene Corporation, an American biotechnology company, for creating a premier innovative biopharma company.

In September 2018, Qilu Pharmaceutical, a leading pharmaceutical company in China, announced the receipt of FDA approval for Palonosetron HCl Injection (2.5mg/5ml), a generic Aloxi® Injection, which is used in the treatment and prevention of chemotherapy-induced vomiting and nausea.

Embolization Particle Market Analysis to Witness an Uptick during 2017 to 2023

Embolization Particle Market Information: By Product Type (Radioembolization & Drug Eluting Beads), Application, (Oncology, Peripheral Vascular Disease, Neurology), Level of Occlusion (Proximal) End User (Hospitals & Clinics) – Global Forecast till 2023

Market Research Future (MRFR), in its recently published market forecast asserts that the global Embolization Particle Market Analysis will register a striking CAGR of 9.64 % throughout the forecast period (2017 – 2023) garnering accruals of USD 1,909.76 Mn. by 2023.

Embolization Particle is a minimally invasive therapy used in many procedures as a part of interventional radiology. Embolization is used to stop bleeding as well as to treat tumors that cannot be removed by surgery by stopping its blood supply. The invention of Embolization Particle in therapeutics has offered some exciting possibilities. While Embolization can also be used with ablation, it may not be a good option for some patients whose liver has been damaged by diseases such as cirrhosis or hepatitis.

The use of Embolization in the field of medicine as a whole has revolutionized the way of diagnosis, treatment, and prevention. Hence, the market for Embolization Particle is blooming currently, with the growing prevalence of cases of tumors. The augmenting demand for noninvasive therapies predominantly drives the market growth.

Also, growing incidence of cancer and other metabolic diseases have fueled the growth of Embolization Particle market. Additional factors contributing to the market growth include the growing population, urbanization and improving economic conditions that are increasing access to the quality healthcare and quality of life of people.

On the other hand, unavailability of interventional neuroradiologists and interventional neuroradiology (INR) labs along with the lack of regulatory standards in the examination of Embolization Particle and higher cost of the treatment are some of the key factors impeding the market growth.

Nevertheless, constant technological development, increasing demand for the better treatment, along with the governmental support is expected to foster the market growth commutatively.

Global Embolization Particle Market Segmentation

Global Embolization Particle Market is segmented into five key dynamics for the convenience of understanding;

By Product Types : Radioembolization and Drug Eluting Beads among others.

By Applications : Oncology, Peripheral Vascular Disease, and Neurology among others.

By Levels of Occlusion : Proximal and Distal among others.

By End-Users : Hospitals, Clinics and ambulatory services among others.

By Regions : North America, Europe, APAC and Rest-of-the-World.

The Radioembolization segment accounted for the largest market share in 2016 and is estimated to grow at 10.01% CAGR approx. during the forecast period from 2017-2023.

Request For Free Sample Copy :

https://www.marketresearchfuture.com/sample_request/4815

Global Embolization Particle Market Regional Analysis

Globally North America leads the Embolization Particle market with the significant market share. The Market is expected to grow phenomenally from 2017 to 2023. Factors substantiating the market growth include the growing number of patients suffering from tumors coupled with the high healthcare expenditures, significant developments in the healthcare domain, and focus of research institutions on advent technologies for new and advanced diagnosis and treatment methods. Well-defined per capita healthcare expenditure is undoubtedly a key driving force behind the market growth in the region.

Moreover, the growing number of centers offering embolization particle therapy coupled with the availability of advanced infrastructures & devices, and availability of skilled healthcare professional contributions to the market growth in the region. The region is expected to reach the valuation of USD 703.13 Mn. by 2023.

The US, backed by the technological advances and availability of funding for the development of new therapeutics and treatment accounts for the major contributor to the market growth. Moreover, the presence of the well-established players also drives the market for Embolization Particle in this region.

Europe emerging as a lucrative market for Embolization Particle will expand with a phenomenal CAGR. The resurging economy in the region is expected to foster the regional market growth. Besides, availability of technologically advanced devices and the proliferation of quality healthcare along with the increasing healthcare cost mushrooms the growth of the market in the region.

Moreover, the accessibility of technology and increasing government support for the research and development support the market growth in the region. Also, factors such as the increasing prevalence of cancer among the population due to the changing lifestyle and the growing emphasis on rapid diagnosis and treatment of cancer substantiate the growth of the market in this region.

Asia Pacific market for the Embolization Particle is expected to perceive the fastest growth by 2023 registering a CAGR of 10.11% from 2017 to 2023. India and China backed by the huge population, and the availability of low-cost therapies will lead the regional market. Moreover, the fastest growing healthcare sector coupled with the large unmet needs over the forecast period will provide impetus to the market growth.

Vietnam, Thailand, and Malaysia among other South East Asian countries are projected to contribute significantly to the regional market growth. Besides the growing penetration of healthcare insurance along with the increase in the demand for various diagnosis & treatment methods, is expected to drive the Embolization Particle market in the in the Asia Pacific region.

Global Embolization Particle Market Competitive Analysis

Key Players are actuated to bring innovations in the therapy with minimum adverse effects, as well as to target emerging applications to leverage growth opportunities. They are focusing on R&D in order to develop the therapy further.

Key Players:

Market players driving the global embolization particle market include Guerbet, Boston Scientific Corporation, BTG International Ltd, Sirtex, Medtronic, Merit Medical, and Terumo. Profiling them in its analysis MRFR finds the strategies helping them to stay at the forefront of competition.